2021-04-28 sec-litreleases litigation_release 65 KB 1,289 chars

SEC v. Mark Ahn, No. LR-25084, District of Massachusetts (Apr. 28, 2021) — Press Release

raw: Mark Ahn

Mark Ahn, No. 1:21-cv-10203 (Apr. 28, 2021)

Caption
Securities & Exchange Commission v. Ahn
Source PDF JSON
summary

Mark Ahn, former consultant and board member, committed insider trading in Dimension Therapeutics securities ahead of an August 2017 merger announcement and was barred from serving as a public company officer or director.

paragraph

Mark Ahn was charged with insider trading in Dimension Therapeutics securities prior to an August 2017 merger announcement. Ahn consented to a partial judgment enjoining him from violating Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5, and was barred from serving as an officer or director of any SEC reporting company. Ahn also pleaded guilty in a parallel criminal action and is awaiting sentencing.

narrative

The U.S. District Court for the District of Massachusetts entered a partial judgment against Mark Ahn, a former consultant and board member of Dimension Therapeutics, Inc., who was charged by the SEC with insider trading in the company's securities prior to an August 2017 merger announcement. Ahn consented to the judgment, which enjoins him from violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. The court also permanently barred Ahn from serving as an officer or director of any SEC reporting company. While the civil penalty remains to be determined by the court at a later date, Ahn has pleaded guilty in a parallel criminal action brought by the U.S. Attorney's Office for the District of Massachusetts. Ahn is scheduled to be sentenced on June 7, 2021. The SEC's complaint was filed on February 5, 2021, alleging Ahn's insider trading violations.

Enriched metadata

Scheme
insider-trading (100%)
Court
District of Massachusetts
Case No.
1:21-cv-10203
Outcome
pleaded · 2021-06-07
Entity
Mark Ahn
Classified insider-trading(confidence 100%). EDGAR detection: forms 4/3/5/144· recall 81% / precision 19%. detection rule →
Statutes
Section 10(b) of the Securities Exchange ActRule 10b-5
Parties
Securities & Exchange CommissionMark J Ahn
Keywords
ahnmarkinsider tradingofficer directorsecurities exchangecompanysecuritiessecbarsinsidertradingservingofficerdirectorexchange

Exhibits & Attached Documents (3)

Extracted insights

Entities 27
  • person against mark ahn
  • scheme_term a previously-filed case charging mark ahn with insider trading
  • scheme_term charging mark ahn with insider trading
  • company dimension therapeutics, inc.
  • agency in an sec case against mark ahn
  • agency in a previously-filed sec case
  • scheme_term insider trading
  • company insider trading in the securities of dimension therapeutics, inc.
  • agency in the sec case
  • agency in the sec case against mark ahn
  • company in the securities of dimension therapeutics, inc.
  • person litigation release
  • person mark ahn
  • scheme_term mark ahn for insider trading
  • agency mark ahn in sec case
  • scheme_term mark ahn with engaging in insider trading
  • scheme_term mark ahn with insider trading
  • location massachusetts
  • company massachusetts-based pharmaceutical company
  • person merger announcement
  • location oregon
  • scheme_term oregon resident mark ahn with engaging in insider trading
  • person partial judgment
  • agency Securities and Exchange Commission
  • company securities of dimension therapeutics, inc.
  • court the u.s. district court
  • court u.s. district court for the district of massachusetts
Triples 72
  • The U.S. District Court entered a partial judgment in a previously-filed SEC case
  • The SEC charged Mark Ahn with engaging in insider trading
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc.
  • The SEC filed a case charging Mark Ahn with insider trading
  • The U.S. District Court entered a partial judgment in the SEC case
  • Court Bars Former Consultant and Board Member
  • Former Consultant and Board Member Charged with Insider Trading
  • Mark Ahn is Former Consultant and Board Member
  • SEC charging Mark Ahn
  • Mark Ahn engaging in insider trading
  • Mark Ahn resides in Oregon
  • Dimension Therapeutics, Inc. is Massachusetts-based pharmaceutical company
  • Merger announcement occurred in August 2017
  • Litigation Release No. 25084 dated April 28, 2021
  • Securities and Exchange Commission v. Mark Ahn
  • U.S. District Court for the District of Massachusetts entered partial judgment
  • The U.S. District Court entered a partial judgment in a previously-filed SEC case
  • The SEC charged Mark Ahn with engaging in insider trading
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc.
  • The SEC announced a previously-filed case charging Mark Ahn with insider trading
  • The U.S. District Court entered a partial judgment in a previously-filed SEC case
  • The SEC charged Mark Ahn with engaging in insider trading
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc.
  • The U.S. District Court entered a partial judgment in a previously-filed SEC case
  • Mark Ahn engaging in insider trading in the securities of a Massachusetts-based pharmaceutical company, Dimension Therapeutics, Inc.
  • The SEC charging Oregon resident Mark Ahn with engaging in insider trading
  • Mark Ahn engaged in insider trading the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • SEC charged Mark Ahn with insider trading
  • U.S. District Court for the District of Massachusetts entered a partial judgment in an SEC case against Mark Ahn
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • SEC charged Mark Ahn with insider trading
  • U.S. District Court for the District of Massachusetts entered a partial judgment in the SEC case against Mark Ahn
  • Mark Ahn engaged in insider trading the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • SEC charged Mark Ahn with insider trading
  • U.S. District Court for the District of Massachusetts entered a partial judgment in the SEC case against Mark Ahn
  • Court Bars Mark Ahn
  • Mark Ahn Charged with Insider Trading
  • SEC Charging Mark Ahn
  • Mark Ahn Engaging in Insider Trading
  • Mark Ahn Resident of Oregon
  • Dimension Therapeutics, Inc. Based in Massachusetts
  • Merger Announcement Date August 2017
  • Litigation Release Number 25084
  • Litigation Release Date April 28, 2021
  • Case Filed February 5, 2021
  • Case Filed in D. Mass.
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • SEC charged Mark Ahn with insider trading
  • U.S. District Court for the District of Massachusetts entered a partial judgment in an SEC case against Mark Ahn
  • Mark Ahn charged with insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • SEC filed case against Mark Ahn for insider trading
  • U.S. District Court for the District of Massachusetts entered partial judgment against Mark Ahn in SEC case
  • Mark Ahn charged with insider trading
  • Mark Ahn engaged in insider trading in securities of Dimension Therapeutics, Inc.
  • Mark Ahn served as former consultant and board member
  • U.S. District Court for the District of Massachusetts entered partial judgment
  • SEC filed case against Mark Ahn
  • Dimension Therapeutics, Inc. announced merger August 2017
  • Mark Ahn barred from serving as public company officer or director
  • U.S. District Court for the District of Massachusetts entered a partial judgment
  • SEC case charging Oregon resident Mark Ahn
  • Mark Ahn engaged in insider trading
  • Mark Ahn traded securities of Dimension Therapeutics, Inc.
  • Court bars Mark Ahn from serving as public company officer or director
  • Litigation Release No. 25084 dated April 28, 2021
  • SEC v. Mark Ahn filed February 5, 2021
  • Mark Ahn is former consultant and board member
  • Mark Ahn charged with engaging in insider trading in the securities of a Massachusetts-based pharmaceutical company, Dimension Therapeutics, Inc., in advance of an August 2017 merger announcement
  • The U.S. District Court entered a partial judgment in a previously-filed SEC case
  • The SEC charged Mark Ahn with engaging in insider trading
  • Mark Ahn engaged in insider trading in the securities of a Massachusetts-based pharmaceutical company, Dimension Therapeutics, Inc.
  • The SEC filed a case charging Oregon resident Mark Ahn
PDF (from attached: judgment)
Plaintiff, the United States Securities and Exchange Commission (the “Commission”), · Source
Text layers
Extracted body text (1,289c) 
Court Bars Former Consultant and Board Member Charged with Insider Trading from Serving as Public Company Officer or Director Litigation Release No. 25084 / April 28, 2021 Securities and Exchange Commission v. Mark Ahn, No. 1:21-cv-10203 (D. Mass. filed February 5, 2021) The U.S. District Court for the District of Massachusetts today entered a partial judgment in a previously-filed SEC case charging Oregon resident Mark Ahn with engaging in insider trading in the securities of a Massachusetts-based pharmaceutical company, Dimension Therapeutics, Inc., in advance of an August 2017 merger announcement. The SEC's complaint, filed on February 5, 2021, charged Ahn with violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. Ahn consented to the partial judgment entered by the court, which enjoins him from violating the above statutes and bars him from serving as an officer or director of any SEC reporting company. Any civil penalty in the SEC matter will be determined by the court at a later date. In a parallel criminal action brought by the U.S. Attorney's Office for the District of Massachusetts, Ahn has pleaded guilty and is scheduled to be sentenced on June 7, 2021. Final Judgement Motion For Judgment Consent
OCR text (1,289c · html-text · 99% conf) 
Court Bars Former Consultant and Board Member Charged with Insider Trading from Serving as Public Company Officer or Director Litigation Release No. 25084 / April 28, 2021 Securities and Exchange Commission v. Mark Ahn, No. 1:21-cv-10203 (D. Mass. filed February 5, 2021) The U.S. District Court for the District of Massachusetts today entered a partial judgment in a previously-filed SEC case charging Oregon resident Mark Ahn with engaging in insider trading in the securities of a Massachusetts-based pharmaceutical company, Dimension Therapeutics, Inc., in advance of an August 2017 merger announcement. The SEC's complaint, filed on February 5, 2021, charged Ahn with violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. Ahn consented to the partial judgment entered by the court, which enjoins him from violating the above statutes and bars him from serving as an officer or director of any SEC reporting company. Any civil penalty in the SEC matter will be determined by the court at a later date. In a parallel criminal action brought by the U.S. Attorney's Office for the District of Massachusetts, Ahn has pleaded guilty and is scheduled to be sentenced on June 7, 2021. Final Judgement Motion For Judgment Consent

Related documents (3)